Poradosu Enrique's Form 4 filing
Nuvectis Pharma, Inc. (NVCT) · filed May 13, 2024
- Accession no.
- 0001104659-24-060262
- Filed
- May 13, 2024
- Trade date
- May 10, 2024
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market purchases total $3.15K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Poradosu EnriqueCIK 0001898147 | Officer (Chief Science & Business Off) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 10, 2024 | Common Stock | PPurchaseAcquired | +500 | $6.29 | +$3,145 | 1,504,319 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.